| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.06 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |